A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma.
Clin Cancer Res
; 29(3): 548-559, 2023 02 01.
Article
in En
| MEDLINE
| ID: mdl-36469573
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pleural Neoplasms
/
Mesothelioma, Malignant
/
Lung Neoplasms
/
Mesothelioma
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article